| Literature DB >> 28304345 |
Nan-Fu Chen1,2, Yin-Di Su3, Tsong-Long Hwang4,5,6, Zuo-Jian Liao7,8, Kuan-Hao Tsui9,10,11,12, Zhi-Hong Wen13,14, Yang-Chang Wu15,16,17, Ping-Jyun Sung18,19,20,21,22.
Abstract
Three new polyoxygenated briarane diterpenoids, briarenols C-E (1-3), were isolated from the octocoral Briareum excavatum. The structures of briaranes 1-3 were elucidated by interpretation of spectroscopic data, and the methylenecyclohexane ring in 1 was found to exist in a twisted boat conformation. Briarenol D (2) displayed an inhibitory effect on the release of elastase by human neutrophils with an IC50 value of 4.65 μM. Briarenol E (3) was found to inhibit the protein expression of pro-inflammatory inducible nitric oxide synthase (iNOS) in a murine macrophage-like cell line, RAW 264.7, stimulated with lipopolysaccharides (LPS).Entities:
Keywords: Briareum excavatum; anti-inflammatory; briarane; briarenol; elastase; iNOS; octocoral
Mesh:
Substances:
Year: 2017 PMID: 28304345 PMCID: PMC6155408 DOI: 10.3390/molecules22030475
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The octocoral Briareum excavatum and the structures of briarenols C–E (1–3) and briarenolide ZI (4).
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H-1H COSY and HMBC correlations for briarane 1.
| Position | δH ( | δC, Multiple | 1H-1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 47.1, C | |||
| 2 | 4.80 d (4.4) | 72.0, CH | H2-3 | C-1, -4, -15, acetate carbonyl |
| 3α/β | 1.96 m; 3.15 dd (12.8, 11.6) | 37.7, CH2 | H-2, H-4 | C-1, -2, -4, -5 |
| 4 | 5.19 dd (12.8, 6.0) | 73.0, CH | H2-3 | C-3, -6, -16 |
| 5 | 144.8, C | |||
| 6 | 5.59 d (10.0) | 123.4, CH | H-7, H3-16 | C-8 |
| 7 | 5.94 d (10.0) | 73.2, CH | H-6 | C-5 |
| 8 | 71.4, C | |||
| 9 | 3.95 br s | 72.3, CH | H-10 | C-17 |
| 10 | 3.39 d (5.2) | 44.4, CH | H-9 | C-1, -2, -9, -11, -12, -15, -20 |
| 11 | 150.6, C | |||
| 12 | 4.51 dd (8.8, 7.6) | 65.5, CH | H2-13 | n.o. a |
| 13α/β | 1.55 m; 2.62 ddd (16.0, 8.8, 4.4) | 37.2, CH2 | H-12, H-14 | C-1, -11, -12, -14 |
| 14 | 4.74 d (4.4) | 74.1, CH | H2-13 | C-1, -10, -12, acetate carbonyl |
| 15 | 1.34 s | 16.4, CH3 | C-1, -2, -10, -14 | |
| 16 | 2.20 d (1.2) | 25.6, CH3 | H-6 | C-4, -5, -6 |
| 17 | 60.6, C | |||
| 18 | 1.53 s | 9.5, CH3 | C-8, -17, -19 | |
| 19 | 171.9, C | |||
| 20a | 5.13 d (1.2) | 109.3, CH2 | H-20b | C-10, -12 |
| b | 5.03 s | H-20a | C-10, -12 | |
| OAc-2 | 170.6, C | |||
| 2.01 s | 20.9, CH3 | Acetate carbonyl | ||
| OAc-4 | 170.3, C | |||
| 1.91 s | 21.1, CH3 | Acetate carbonyl | ||
| OAc-14 | 170.3, C | |||
| 2.04 s | 21.0, CH3 | Acetate carbonyl |
a n.o. = not observed.
Figure 2Selected protons with key NOESY correlations of 1.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H-1H COSY and HMBC correlations for briarane 2.
| Position | δH ( | δC, Multiple | 1H-1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 48.0, C | |||
| 2 | 5.01 d (7.2) | 72.5, CH | H2-3 | C-1, -3, -4, -10, -15, acetate carbonyl |
| 3α/β | 2.00 m; 3.07 dd (15.2, 12.4) | 37.6, CH2 | H-2, H-4 | C-1, -2, -4, -5 |
| 4 | 5.08 dd (12.4, 5.6) | 72.8, CH | H2-3 | C-3, -5, -6, -16, acetate carbonyl |
| 5 | 143.6, C | |||
| 6 | 5.47 ddd (9.6, 1.2, 1.2) | 123.4, CH | H-7, H3-16 | C-4, -16 |
| 7 | 5.91 d (9.6) | 74.2, CH | H-6 | C-5, -6, -19 |
| 8 | 71.2, C | |||
| 9 | 4.35 br s | 73.4, CH | H-10, OH-9 | C-8, -10, -11 |
| 10 | 2.96 d (2.8) | 44.1, CH | H-9 | C-1, -2, -8, -9, -11, -12, -14, -15, -20 |
| 11 | 151.5, C | |||
| 12 | 4.31 dd (6.8, 6.8) | 69.7, CH | H2-13 | C-10, -11, -13, -14, -20 |
| 13α/β | 2.19 ddd (15.2, 6.8, 3.2); 1.81 ddd (15.2, 6.8, 3.6) | 36.6, CH2 | H-12, H-14 | C-1, -11, -12, -14 |
| 14 | 4.76 dd (3.6, 3.2) | 73.8, CH | H2-13 | C-10, -12 |
| 15 | 1.30 s | 14.7, CH3 | C-1, -2, -10, -14 | |
| 16 | 2.11 d (1.2) | 25.4, CH3 | H-6 | C-4, -5, -6 |
| 17 | 62.2, C | |||
| 18 | 1.52 s | 10.0, CH3 | C-8, -17, -19 | |
| 19 | 172.0, C | |||
| 20a | 5.29 s | 110.9, CH2 | H-20b | C-10, -11, -12 |
| b | 5.07 s | H-20a | C-10, -11, -12 | |
| OAc-2 | 170.4, C | |||
| 2.01 s | 21.0, CH3 | Acetate carbonyl | ||
| OAc-4 | 170.3, C | |||
| 2.04 s | 21.0, CH3 | Acetate carbonyl | ||
| OAc-14 | 170.6, C | |||
| 1.96 s | 21.3, CH3 | Acetate carbonyl | ||
| OH-9 | 3.00 d (4.8) | H-9 |
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data and 1H–1H COSY and HMBC correlations for briarane 3.
| Position | δH ( | δC, Multiple | 1H-1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 45.3, C | |||
| 2 | 4.99 d (6.4) | 73.9, CH | H2-3 | C-1, -3, -10, -14, -15, acetate carbonyl |
| 3α/β | 1.34 dd (15.6, 4.8); 3.37 ddd (15.6, 12.8, 6.4) | 35.8, CH2 | H-2, H-4 | C-1, -2, -4, -5 |
| 4 | 4.80 dd (12.8, 4.8) | 76.3, CH | H2-3 | C-2, -3, -6, -8, -16 |
| 5 | 138.0, C | |||
| 6 | 5.51 ddd (2.8, 2.4, 2.4) | 55.1, CH | H-7, H2-16 | C-5, -16 |
| 7 | 4.74 d (2.8) | 80.5, CH | H-6 | C-5, -6 |
| 8 | 82.0, C | |||
| 9 | 4.87 d (3.6) | 76.3, CH | OH-9 | C-1, -8, -10, -11, -17 |
| 10 | 2.16 s | 40.4, CH | n.o. a | C-1, -2, -8, -9, -11, -12, -14, -15 |
| 11 | 78.4, C | |||
| 12 | 3.49 m | 76.2, CH | H2-13, OH-12 | n.o. |
| 13α/β | 1.96 ddd (15.6, 3.6, 2.8); 2.43 ddd (15.6, 4.0, 2.8) | 28.0, CH2 | H-12, H-14 | C-1, -12, -14 |
| 14 | 5.18 dd (2.8, 2.8) | 76.4, CH | H2-13 | C-2, -10, -12, acetate carbonyl |
| 15 | 1.53 s | 16.6, CH3 | C-1, -2, -10, -14 | |
| 16a | 5.29 d (2.4) | 115.7, CH2 | H-6, H-16b | C-4, -6 |
| b | 5.46 d (2.4) | H-6, H-16a | C-4, -5, -6 | |
| 17 | 2.59 q (7.2) | 50.2, CH | H3-18 | C-8, -9, -18, -19 |
| 18 | 1.29 d (7.2) | 8.2, CH3 | H-17 | C-8, -17, -19 |
| 19 | 175.9, C | |||
| 20 | 1.54 s | 29.5, CH3 | C-10, -11, -12 | |
| OAc-2 | 170.8, C | |||
| 1.99 s | 21.2, CH3 | Acetate carbonyl | ||
| OAc-14 | 169.2, C | |||
| 2.04 s | 21.1, CH3 | Acetate carbonyl | ||
| OH-9 | 2.78 d (3.6) | H-9 | C-8, -9 | |
| OH-12 | 2.71 d (9.2) | H-12 |
a n.o. = not observed.
Inhibitory effects of briaranes 1–3 on superoxide anion generation and elastase release by human neutrophils in response to fMet-Leu-Phe/Cytochalastin B.
| Compound | Superoxide Anions | Elastase Release |
|---|---|---|
| IC50 (μM) a | IC50 (μM) | |
| >10 | >10 | |
| >10 | 4.65 ± 1.50 | |
| >10 | >10 | |
| 1.39 ± 0.32 | 3.30 ± 0.11 |
a Concentration necessary for 50% inhibition (IC50); results are presented as mean ± S. E. M. (n = 3). b LY294002 (2-morpholin-4-yl-8-phenylchromen-4-one) was used as reference compound.
Effects of briaranes 1–3 on LPS-induced iNOS and COX-2 protein expression in macrophages.
| Compound | iNOS | COX-2 |
|---|---|---|
| Expression (% of LPS Group) | Expression (% of LPS Group) | |
| Control | 0.79 ± 0.01 | 1.00 ± 0.02 |
| LPS | 100.00 ± 7.48 | 100.00 ± 18.39 |
| 1 | 93.22 ± 22.59 | 100.41 ± 1.08 |
| 2 | 78.35 ± 0.73 | 94.28 ± 21.35 |
| 3 | 66.86 ± 3.86 | 119.42 ± 1.33 |
| DEX a | 56.18 ± 4.53 | 17.42 ± 2.53 |
a Dexamethasone (DEX, 10 μM) was used as a positive control.